Carregant...

Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

BACKGROUND: Our objective was to determine if previously reported overall survival (OS) and progression-free survival (PFS) rates are maintained long term following multimodal therapy for advanced and recurrent endometrial cancer and to assess the lymphedema rates associated with this therapy. METHO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol Res Pract
Autors principals: Glasgow, Michelle, Vogel, Rachel Isaksson, Burgart, Jennifer, Argenta, Peter, Dusenbery, Kathryn, Geller, Melissa A.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940984/
https://ncbi.nlm.nih.gov/pubmed/27408749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-016-0027-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!